Baird Financial Group
RXST icon

Baird Financial Group’s RxSight RXST Stock Holding History

Baird Financial Group’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-70,039
Closed -$3.46M – 1798
2024
Q3 		$3.46M Buy
70,039
+21,133
+43% +$1.08M 0.01% 803
2024
Q2 		$2.94M Buy
+48,906
New +$2.79M 0.01% 844

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baird Financial Group's RXST Position: Q4 2024 in Review

Baird Financial Group sold out of RxSight (RXST) in Q4 2024, closing a stake of 70,039 shares — an estimated $3.46M sold.

Baird Financial Group first reported a position in RXST in Q2 2024 and held it in 2 quarters. The position peaked at $3.46M in Q3 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Baird Financial Group reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Baird Financial Group sold 70,039 RxSight shares in Q4 2024, an estimated $3.46M.
  • Baird Financial Group first reported a position in RxSight in Q2 2024 and held it in 2 quarters.
  • Baird Financial Group's RxSight position peaked at $3.46M in Q3 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Baird Financial Group's 13F filing for Q4 2024, filed 14 Feb 2025.